abstract gray background

Archives: Resources

PPD | Overview
Hematology oncology overview brochure
  • External Link

Download our hematology oncology brochure to learn about our specialized approach to hematology oncology studies.

Read More
PPD | report
Harnessing Real-World Data and Evidence to Accelerate Drug Development

Discover ways that RWE accelerates development, de-risks decisions and unlocks real-world success.

Read the report
PPD | White Paper
How is clinical research evolving in IPF and other rare respiratory diseases?

Understand the key considerations shaping IPF and rare respiratory disease trials, from early diagnosis to precision-guided development.

Get the white paper
PPD | White Paper
Transforming Effective Patient Recruitment

Explore modern, data-driven approaches to patient recruitment that improve engagement, speed enrollment, and strengthen clinical trial performance.

Get the white paper
PPD | White Paper
Minimizing Non‑Enrolling Sites to Improve Clinical Trial Outcomes

Explore how targeted site engagement, CRA training, data tools, and PRELs reduce non-enrolling sites, speed enrollment, and strengthen trial outcomes.

Get the white paper
PPD | Brochure
Accelerate development with a smarter, fit-for-purpose RWD strategy

Discover how RWD Optimization Framework aligns evidence needs, expands fit-for-purpose data, ensures quality, and speeds development.

Read brochure
PPD | Resource
Exploring biomarker testing in clinical research

Explore biomarker testing in clinical research, including common analysis types and the development and validation of bioanalytical methods.

Listen to the podcast
PPD | Webinar
Research-based insights to guide CDMO-CRO partnership decisions

Explore how integrating CDMO, CRO, and clinical supply with one partner shortens timelines, reduces costs, improves control, and accelerates drug development.

Read More
PPD | Presentation
Strategic Insights From 5 Years of the EU HTAR: Unleashing the Ambition for Orphan Products and Vaccines

Explore guidance from 5 years of EU HTAR experience, including Smart PICO, early readiness, and evidence strategies for orphan drugs and vaccines.

Watch the recording